Small fiber peripheral neuropathy
|This article needs additional citations for verification. (October 2009) (Learn how and when to remove this template message)|
|Small fiber peripheral neuropathy|
|Classification and external resources|
|ICD-10||G63.3 G60.8 G62.8|
Small fiber peripheral neuropathy is a type of peripheral neuropathy that occurs from damage to the small unmyelinated peripheral nerve fibers. These fibers, categorized as C fibers, are present in skin, peripheral nerves, and organs. The role of these nerves is to innervate the skin (somatic fibers) and help control autonomic function (autonomic fibers). It is estimated that 15-20 million people in the United States suffer from some form of peripheral neuropathy.
Sensory symptoms of small fiber neuropathy are highly variable. Common complaints include paresthesias, dysesthesias, and insensitivity to pain. Paresthesias are abnormal sensations. They are often described as numbness, burning, cold, prickling, pins and needles along with other symptoms. Dysesthesias are unpleasant sensations, either spontaneous or evoked. A light breeze, the feeling of clothes, or even a soft touch can cause pain. Insensitivity to pain can be particular problem. One may be bleeding or have a skin injury without even knowing it.
Like many polyneuropathies, the symptoms are length-dependent, starting in the longer nerves and progressively attack shorter nerves. This means that most often the symptoms start in the feet and progress upwards, and usually symptoms are more severe in the feet. Many patients have a widespread, non-length dependent, or "patchy", which the presentation is more sporadic and can effect many nerves, including the trigeminal nerve or occipital nerve.
Patients with Fabry disease have isolated small fiber engagement, and can have a more widespread small fiber disruption.
The diagnosis of small fiber neuropathy often requires ancillary testing. Nerve conduction studies and electromyography are commonly used to evaluate large myelinated sensory and motor nerve fibers, but are ineffective in diagnosing small fiber neuropathies.
Quantitative sensory testing (QST) assesses small fiber function by measuring temperature and vibratory sensation. Abnormal QST results can be attributed to dysfunction in the central nervous system. Furthermore, QST is limited by a patient’s subjective experience of pain sensation. Quantitative sudomotor axon reflex testing (QSART) measures sweating response at local body sites to evaluate the small nerve fibers that innervate sweat glands.
A skin biopsy for the measurement of epidermal nerve fiber density is an increasingly common technique for the diagnosis of small fiber peripheral neuropathy. Physicians can biopsy the skin with a 3-mm circular punch tool, and send the sample to a specialized laboratory for processing and analysis. Small nerve fibers are quantified by a neuropathologist to obtain a diagnostic result.
This skin punch biopsy measurement technique is called intraepidermal nerve fiber density (IENFD). The following table describes the IENFD values in males and females of a 3 mm biopsy 10-cm above the lateral malleolus (above ankle outer side of leg). Any value measured below the 0.05 Quantile IENFD values per age span, is considered a reliable positive diagnosis for Small Fiber Peripheral Neuropathy.
An example: a woman 26 years of age has an IENFD value of 8.0, looking at the table, the value lies below the 0.05 quantile IENFD (8.4), meaning that this woman is positive for a diagnosis of Small fiber peripheral neuropathy.
|Age in years||0.05 Quantile IENFD values per age span||Median IENFD values per age span||0.05 Quantile IENFD values per age span||Median IENFD values per age span|
There are many possible causes of small fiber neuropathy. The most common cause is diabetes or glucose intolerance. Other possible causes include hypothyroidism, Sjögren's syndrome, Lupus, vasculitis, sarcoidosis, nutritional deficiency, Celiac disease, Lyme disease, HIV, Fabry disease, amyloidosis and alcoholism. A 2008 study reported that in approximately 40% of patients no cause could be determined after initial evaluation. When no cause can be identified, the neuropathy is called idiopathic. A recent study revealed dysfunction of a particular sodium channel (Nav1.7) in a significant portion of the patient population with an idiopathic small fiber neuropathy.
Recently several studies have suggested an association between autonomic small fiber neuropathy and postural orthostatic tachycardia syndrome. Other notable studies have shown a link between erythromelalgia, and fibromyalgia. SFN is a common feature in adults with Ehlers-Danlos Syndrome (EDS). Skin biopsy could be considered an additional diagnostic tool to investigate pain manifestations in EDS.
||The examples and perspective in this section deal primarily with USA and do not represent a worldwide view of the subject. (December 2010) (Learn how and when to remove this template message)|
Treatment is based on the underlying cause, if any. Where the likely underlying condition is known, treatment of this condition is indicated treated to reduce progression of the disease and symptoms. For cases without those conditions, there is only symptomatic treatment.
- Overview of Small Fiber Neuropathy. Therapath Pathology.
- Tavee, Jinny; Zhou, Lan (May 2009). "Small fiber neuropathy: A burning problem". Cleveland Clinic Journal of Medicine. 76 (5): 297–305. doi:10.3949/ccjm.76a.08070. ISSN 0891-1150. PMID 19414545.
- Latov, Norman (2007). Peripheral Neuropathy: When the Numbness, Weakness and Pain Won't Stop. American Academy of Neurology (AAN) quality of life guides. Demos Medical Publishing. p. 8. ISBN 9781932603590.
- Hovaguimian A, Gibbons CH (June 2011). "Diagnosis and treatment of pain in small-fiber neuropathy". Curr Pain Headache Rep. 15 (3): 193–200. doi:10.1007/s11916-011-0181-7. PMC . PMID 21286866.
- Lauria G, Hsieh ST, Johansson O, et al. (July 2010). "European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy.". Eur. J. Neurol. 17 (7): 903–12, e44–9. doi:10.1111/j.1468-1331.2010.03023.x. PMID 20642627.
- Lacomis D (August 2002). "Small-fiber neuropathy". Muscle Nerve. 26 (2): 173–88. doi:10.1002/mus.10181. PMID 12210380.
- Lauria, G; Bakkers, M; Schmitz, C; Lombardi, R; Penza, P; Devigili, G; Smith, AG; Hsieh, ST; Mellgren, SI; Umapathi, T; Ziegler, D; Faber, CG; Merkies, IS (September 2010). "Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study.". Journal of the peripheral nervous system : JPNS. 15 (3): 202–7. doi:10.1111/j.1529-8027.2010.00271.x. PMID 21040142.
- Polydefkis, M; et al. (2003). "New insights into diabetic polyneuropathy". JAMA. 290: 1371–6. doi:10.1001/jama.290.10.1371.
- Devigili, G; et al. (2008). "The diagnostic criteria for small fiber neuropathy; from symptoms of neuropathology". Brain. 131: 1912–1925. doi:10.1093/brain/awn093.
- Faber, C; et al. (2011). "Gain of function Na(V) 1.7 mutations in idiopathic small fiber neuropathy". Annals of Neurology. doi:10.1002/ana.22485.
- Davis, Mark DP; Weenig, Roger H; Genebriera, Joseph; Wendelschafer-Crabb, Gwen; Kennedy, William R; Sandroni, Paola (September 2006). "Histopathologic findings in primary erythromelalgia are nonspecific: special studies show a decrease in small nerve fiber density". Journal of the American Academy of Dermatology. 55 (3): 519–522. doi:10.1016/j.jaad.2006.04.067. ISSN 0190-9622. PMID 16908366.
- Levine, Todd D; Saperstein, David S (March 2015). "Routine use of punch biopsy to diagnose small fiber neuropathy in fibromyalgia patients". Clinical Rheumatology. 34 (3): 413–417. doi:10.1007/s10067-014-2850-5. ISSN 0770-3198. PMC . PMID 25535201.